SRTA — Strata Critical Medical Income Statement
0.000.00%
Last trade - 00:00- $424.80m
- $311.38m
- $248.69m
- 77
- 54
- 56
- 68
Annual income statement for Strata Critical Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 23.4 | 50.5 | 146 | 225 | 249 |
| Cost of Revenue | |||||
| Gross Profit | 2.33 | 10.8 | 23.7 | 46.7 | 62.6 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 33.8 | 76.3 | 200 | 293 | 283 |
| Operating Profit | -10.4 | -25.8 | -53.5 | -68.1 | -33.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.2 | -43.7 | -28 | -57.5 | -27.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -10.2 | -40.1 | -27.3 | -56.1 | -27.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -10.2 | -40.1 | -27.3 | -56.1 | -27.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -10.2 | -40.1 | -27.3 | -56.1 | -27.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.147 | -0.908 | -0.355 | -0.579 | -0.274 |
| Dividends per Share |